Arcus Biosciences (RCUS) Capital Expenditures (QoQ) (2017 - 2025)
Arcus Biosciences (RCUS) Capital Expenditures (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcus Biosciences | 3.73 Bn | 2.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 116.67% |
| Dec 31, 2024 | 70.00% |
| Sep 30, 2024 | -766.67% |
| Jun 30, 2024 | 200.00% |
| Mar 31, 2024 | -91.67% |
| Dec 31, 2023 | 200.00% |
| Mar 31, 2023 | 300.00% |
| Dec 31, 2022 | -33.33% |
| Sep 30, 2022 | 250.00% |
| Jun 30, 2022 | -166.67% |
| Mar 31, 2022 | 286.92% |
| Dec 31, 2021 | -131.62% |
| Sep 30, 2021 | 255.94% |
| Jun 30, 2021 | -216.92% |
| Mar 31, 2021 | 71.11% |
| Dec 31, 2020 | 31.42% |
| Sep 30, 2020 | 1,772.97% |
| Jun 30, 2020 | -135.41% |
| Mar 31, 2020 | 6.63% |
| Dec 31, 2019 | -64.36% |